Telo Genomics is a pioneering brand in the field of genomics, specializing in innovative technologies that revolutionize the diagnosis and treatment of various diseases. Led by a team of renowned experts, the brand is dedicated to advancing the understanding of complex diseases like multiple myeloma. At the forefront of Telo Genomics' offerings is their cutting-edge technology called TeloView®, which provides a comprehensive view of telomeres, crucial components of our DNA.

Through this technology, Telo Genomics can identify novel targets and validate targeted therapies, resulting in improved patient outcomes. The brand's exceptional leadership team comprises accomplished individuals who bring immense expertise to the table. Guido Baechler serves as the Chairman, with Dr.

Sabine Mai as the Founder and Director. Kris Weinberg takes on the role of CEO, while Sherif Louis, PhD, is the President and CTO. Chris Ross, CPA, CGA, acts as the CFO, and John Meekison is the Director & Chair of the Audit Committee.

Telo Genomics proudly collaborates with esteemed institutions like the Mayo Clinic and works closely with investors who share their vision. For inquiries, collaborations, or career opportunities, individuals can get in touch with the brand. Telo Genomics is located at the prestigious MaRS Centre in Toronto, Canada